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Abstract
Background: Nr2e1 (nuclear receptor subfamily 2, group e, member 1) encodes a transcription factor important in
neocortex development. Previous work has shown that nuclear receptors can have hundreds of target genes, and
bind more than 300 co-interacting proteins. However, recognition of the critical role of Nr2e1 in neural stem cells
and neocortex development is relatively recent, thus the molecular mechanisms involved for this nuclear receptor
are only beginning to be understood. Serial analysis of gene expression (SAGE), has given researchers both
qualitative and quantitative information pertaining to biological processes. Thus, in this work, six LongSAGE mouse
libraries were generated from laser microdissected tissue samples of dorsal VZ/SVZ (ventricular zone and
subventricular zone) from the telencephalon of wild-type (Wt) and Nr2e1-null embryos at the critical development
ages E13.5, E15.5, and E17.5. We then used a novel approach, implementing multiple computational methods
followed by biological validation to further our understanding of Nr2e1 in neocortex development.
Results: In this work, we have generated a list of 1279 genes that are differentially expressed in response to altered
Nr2e1 expression during in vivo neocortex development. We have refined this list to 64 candidate direct-targets of
NR2E1. Our data suggested distinct roles for Nr2e1 during different neocortex developmental stages. Most
importantly, our results suggest a possible novel pathway by which Nr2e1 regulates neurogenesis, which includes
Lhx2 as one of the candidate direct-target genes, and SOX9 as a co-interactor.
Conclusions: In conclusion, we have provided new candidate interacting partners and numerous well-developed
testable hypotheses for understanding the pathways by which Nr2e1 functions to regulate neocortex development.
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Background
The proper development of the mammalian neocortex
involves a balance between cell-intrinsic developmental
programs and environmental factors. In this process,
neurons acting as the backbone of the neuronal circuitry
are generated first. These cells arise from the dorsal
telencephalon, generating cortical excitatory neurons by
radial migration, and the ventral telencephalon giving
rise to cortical inhibitory interneurons by tangential
migration [1–5]. The neurogenic stage is followed by the
integration of glial cells in the circuitry during the
gliogenic stage. In mice, neurons are generated from em-
bryonic day 12 (E12) to E18, with astrocytes appearing
at around E18 [6, 7]. Ultimately, the neocortex will
comprise six different radial layers with cell populations
having distinct molecular identities [8].
Nr2e1 (nuclear receptor subfamily 2, group e, member
1, also known as Mtll, Tlx, Tll, and tailless) encodes a
transcription factor important in the process of neocor-
tex development [9, 10]. This complex cellular process
involves a careful balance between proliferation of neural
stem cells (NSC), and the proper temporal differenti-
ation of progenitor cells (PC) (i.e. neurons versus glia).
Nr2e1 is expressed along the ventricular zone (VZ) of
the dorsal telencephalon during neocortex development
and is crucial for NSC self-renewal and maintenance
[11–14]. Absence of Nr2e1 in mouse embryos reduces
the number of PC populating the VZ and subventricular
zone (SVZ) during development, which results in re-
duced thickness of the cortical plate [9]. The reduction
in PC populating the VZ is more prominent in the cau-
dal telencephalon whereas the reduction in the SVZ is
seen at all rostrocaudal levels during development. This
cell-reduction ultimately results in defects in structures
generated later, such as the upper cortical layers (layers II
and III), the dentate gyrus, and the olfactory bulb [9, 10].
Absence of Nr2e1 in mouse embryos also results in
premature neurogenesis, which contributes to the defects
in the upper cortical layers [9].
Previous work has shown that a nuclear receptor tran-
scription factor can have hundreds of target genes [15],
and the most extensively studied nuclear receptors are
estimated to bind more than 300 co-interacting proteins
[16, 17]. However, recognition of the critical role of nu-
clear receptor Nr2e1 in NSC and neocortex development
is relatively recent [11, 12, 18–20], thus the molecular
mechanisms involved for this nuclear receptor are only
beginning to be understood. First, in forebrain develop-
ment, Nr2e1 has been shown to regulate cell cycle pro-
gression via its interaction with the tumour suppressor
gene Pten, and the cyclin-dependent kinase inhibitor
p21 [11]. This involves a repressive mechanism mediated
via the interaction of Nr2e1 with chromatin modifier
proteins such as members of the histone deacetylase
family (HDACs), and the demethylase protein LSD1
(KDM1A) [14, 21]. Second, the balance between NSC
proliferation and differentiation has been demonstrated to
be under the control of regulatory loops involving both
Nr2e1, and microRNA encoding genes such as mir-9,
miR-137, and let-7d [22–24]. This phenomenon includes
an intricate network formed by the ability of let-7d and
mir-9 to silence Nr2e1 expression by binding the 3′ UTR
regions of this gene and the ability of Nr2e1 to inactivate
the expression of mir-9 in a first feedback loop [22, 24]. A
second loop has been reported that includes the repres-
sion of the co-interactor Lsd1 by miR-137 that can be re-
lieved by the repression of miR-137 by Nr2e1 [23]. Finally,
Nr2e1 has been shown to act as a transcriptional activator
of the deacetylase gene Sirt1, which has a role in promot-
ing neuronal differentiation [25, 26]. Thus, we hypothesize
there is still much to learn about the molecular mecha-
nisms underlying the role of NR2E1 in NSC and neocor-
tex development. Hence, we have undertaken additional
research on these mechanisms, especially focused on in
vivo analyses, to inform our understanding of neocortex
development.
Large-scale transcriptome-profiling experiments, using
methodologies such as serial analysis of gene expression
(SAGE), have given researchers the advantages of both
qualitative and quantitative information pertaining to
biological processes. SAGE analysis relies on sequencing
and quantification of short (14 bp) cDNA fragments
called tags, which are derived from messenger RNA
transcripts [27]. This approach is considered an open
transcriptome technology as no a priori knowledge of
the transcript sequences is required [28]. For the mam-
malian central nervous system, SAGE profiling experi-
ments have been used to generate knowledge on a
variety of topics including; fundamental studies on brain
development [29], connectivity, and aging [30–32], as
well as specific neuropathologies and drug responses
[33–36]. Advancement in SAGE library generation such
as SAGE-lite [37], which enabled the use of extremely
small quantities of tissues such as those from laser
capture microdissection (LCM), and LongSAGE, which
improved tag-to-gene mapping by generating longer tag
fragments (21 bp) [38], made these approaches particu-
larly appropriate to reveal in vivo molecular changes in
neocortex development. One of the inherent challenges
in transcriptome profiling is the effective analysis of
large-scale datasets to optimize extraction of relevant
biological meaning. By producing LongSAGE libraries at
multiple developmental times, in the presence and
absence of Nr2e1, we generated a rich dataset for com-
parative analysis. Additionally, we took advantage of the
intrinsic nature of transcription factors, which regulate
gene expression by binding to specific DNA sequences,
and used it to further hone our gene list. This was partly
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based on the power of transcription-factor-discovery-
motif algorithms that, when coupled to cross-species
genome comparisons or phylogenetic footprinting, have
proven successful in making reliable binding site predic-
tions [39–42]. Returning to biology to further validate
the bioinformatic studies, we of course used the litera-
ture, but most importantly, we also tested our primary
new hypothesis in vitro by embryonic stem cells (ESC)
differentiation and in vivo during brain development.
Thus, in this work, we used a novel approach, imple-
menting multiple computational methods to generate
significant-novel-biological information regarding the
molecular mechanisms underlying the role of nuclear
receptor Nr2e1 in neocortex development.
Results and discussion
LongSAGE libraries generated from laser capture
microdissection tissues
To identify novel-candidate-target and co-interacting
genes for the nuclear receptor Nr2e1, we favoured an
in vivo source of RNA in order to most accurately
capture molecular events occurring during neocortex
development. Thus, LongSAGE libraries were prepared
using RNA purified from tissues obtained by LCM of
the VZ/SVZ, of the dorsal-lateral telencephalon, from
Wt and Nr2e1frc/frc embryos. This work was under-
taken at three different developmental time points
(E13.5, E15.5, and E17.5), which are known to express
Nr2e1 in the dissected region [9, 11, 18, 43] (Fig. 1a).
These libraries were sequenced to a depth ≥100,000
tags (total number of tags per libraries, see Fig. 1b).
To generate tags for analysis, we used a filtering pro-
cedure involving the DiscoverySpace 4.0 application
(http://www.bcgsc.ca/platform/bioinfo/software/ds) (fil-
tering details, see Methods) [44]. On average, ~24 % of
the total tags per library were discarded in this procedure
resulting in a useful tag population averaging ~83,000 tags
per library, and corresponding to ~25,000 tag types per
library (Fig. 1b). Singleton tags (tags counted only once)
constituted ~18 % of the useful tags population per library
and ~68 % of the tag type population per library (Fig. 1b).
These numbers were consistent with previously published
results, obtained using a similar filtering procedure [45].
LongSAGE libraries differential statistical analyses and
gene IDs recovery
The Audic-Claverie significance test, implemented in the
DiscoverySpace 4.0 application, was used to perform statis-
tical analyses on the filtered tags [44, 46]. Tags differentially
expressed between Wt and Nr2e1frc/frclibraries at each time
point (E13.5, E15.5, and E17.5), and falling within the confi-
dence interval of 95 % (P < 0.05), according to the Audic-
Claverie significance test, were retained for further analyses.
The results for tags significantly increased or decreased in
abundance at each time point are shown in Fig. 2a. The
proportion of differentially abundant tags (either increased
or decreased) varied between 15 to 25 % when compared
to the combined numbers of useful tags found in the Wt
and Nr2e1frc/frc library at each time point (e.g. (Up at E13.5
“Tags (P < 0.05)” (Fig. 2a)/(Wt +Nr2e1frc/frc at E13.5 “Total
useful tags” (Fig. 1b))) × 100). LongSAGE tags were mapped
to RefSeq (v52) and Ensembl (v66) databases [45]. On aver-
age, 52 % of the differentially abundant tags mapped
to genes (average of (“Tags mapped to genes”/“Tags
(P < 0.05)”)×100 for each library, Fig. 2a). The number
of Refseq accession IDs corresponding to differentially
abundant tags at the three different time points are also
shown in Fig. 2a. These accession numbers, corresponding
to Refseq genes, were retrieved and used in the subse-
quent analyses.
We next looked at the genes that were differentially
regulated between the Wt and Nr2e1frc/frc libraries at the
E13.5, E15.5, and E17.5 time points. This resulted in a
total of 1279 Refseq accession numbers, originating
from a corresponding list of 1387 tag sequences
(Additional file 1: Table S1 and Additional file 2: Table S2),
and distributed according to the Venn diagram in Fig. 2b.
Interestingly, when performing the analyses, on average
6 genes per time point corresponded to tags that were
found in both the up and down regulated populations
(data not shown). This suggested that the tags mapped
to these genes were corresponding to alternative tran-
scripts that were expressed in opposing directions when
comparing Wt and Nr2e1frc/frc libraries. The Venn
diagram results also demonstrated that on average
54 % of the differentially-regulated genes (combined
up and down) were specific for each time point: E13.5,
59 % ((383/650) × 100); E15.5, 59 % ((423/711) × 100);
and E17.5, 44 % ((146/333) × 100). Furthermore, on
average 17 % of the genes overlapped between at least
two time points: E13.5 and E15.5, 20 % (((140 + 88)/
(650 + 423 + 60)) × 100); E15.5 and E17.5, 17 % (((88 +
60)/(711 + 146 + 39)) × 100); and E13.5 and E17.5, 15 %
(((88 + 39)/(650 + 146 + 60)) × 100). Finally, only 6.9 %
of the genes overlapped between the three time points
((88/1279) × 100).
LongSAGE expression results suggested distinct roles for
Nr2e1 in different stages of neocortex development
To understand the role of Nr2e1 in gene expression dur-
ing neocortex development, we performed hierarchical
clustering on the tag ratio values corresponding to each
of the 1279 Refseq accession numbers of differentially-
regulated genes (Fig. 3, Additional file 1: Table S1 and
Additional file 2: Table S2). Tag sequences and corre-
sponding tag counts of the 1279 Refseq accession num-
bers were retrieved for each LongSAGE library using the
DiscoverySpace 4.0 application. Fold changes from tags
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statistically differentially abundant, at least at one time
point between the Wt and Nr2e1frc/frc libraries, were cal-
culated as previously described [45], and hierarchical
clustering was performed using the Gene Cluster soft-
ware as described in Methods [47]. The clustering re-
sults were visualized in a heat-map display using Java
TreeView (Fig. 3a) [48]. Spearman-rank-ordering correl-
ation was additionally performed on the fold changes
dataset at each time point as described in Methods. The
results demonstrated that at the E13.5 and E15.5 time-
points, differential tag ratios correlated positively
(Spearman R = 0.28, P < 0.001). In contrast, comparing
E13.5 and E17.5, as well as E15.5 and E17.5 yielded negative
correlation values (E13.5 vs. E17.5, Spearman R =−0.24, P
< 0.001; E15.5 vs. E17.5, Spearman R = −0.23, P < 0.001)
(Fig. 3b). This demonstrated that the differential-tag ratio
found between the E13.5, and E15.5 libraries were more
similar than the one observed in the E17.5 library. This also
suggested that Nr2e1 expression has a more similar effect
on genes in early and mid-stages of neurogenesis, than
during the switch from neurogenesis to gliogenesis occur-
ring around E17.5. These results correlated with previously
published observations, demonstrating a progression of the
Nr2e1-null phenotype during neocortex development, with
a greater effect between E13 and E15 [9].
Bioinformatics analyses for the prediction of Nr2e1 direct
targets
Considering that Nr2e1 encodes for a transcription fac-
tor, and that transcription factors regulate transcription
by binding the promoter regions of their target genes;
we hypothesized that a list of genes, differentially regu-
lated between Wt and Nr2e1frc/frc, would comprise genes
containing Nr2e1 binding sites within their promoter
regions. Thus, interrogation of our pooled list of 1279
Refseq accession numbers was undertaken using three
different software tools; the ORCA toolkit (tk) to per-
form the initial orthologous-sequence alignment and
Fig. 1 Laser microdissected LongSAGE libraries were used to reveal the transcriptome of Wt and Nr2e1frc/frc embryos. a The laser capture
microdissection (LCM) procedure. ((a), I-IV) Embryonic day 13.5 sagittal sections stained with cresyl violet. ((a), II) The ventricular/subventricular
zone (VZ/SVZ) of the dorsal lateral telencephalon cut with laser. ((a), III) The VZ/SVZ removed by LCM. ((a), IV) The VZ/SVZ of the dorsal lateral
telencephalon captured by LCM for RNA extraction. LV, Lateral Ventricle; Str, striatum. Scale bars, 100 μm. b The composition of LongSAGE
libraries. Column one presents the name of the library; columns two and three, the genotype and developmental stage respectively; column
four, the amount of RNA used as starting material; and columns five to nine, the number of tags for each library depending on the filtering
criteria used
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phylogenetic footprinting [49], a customized version of
oPOSSUM for prediction and storage of transcription
factor binding sites (TFBSs) (http://www.cisreg.ca/
oPOSSUM/) [39, 40], and a DAVID GO term analysis
to evaluate if the resulting genes were found in bio-
logical processes relevant to Nr2e1 (http://david.abcc.n-
cifcrf.gov/summary.jsp) [50, 51]. The “modified” version
of the oPOSSUM database used a position-weight matrix
(PWM) that we designed based on the nine sequences
available from the literature, which were known to be
bound by NR2E1 (Additional file 3: Table S3) [21, 22,
52–56]. The resulting matrix and logo are depicted in Fig. 4a.
The results from these sequential analyses are summa-
rized in the flowchart of Fig. 4b. ORCAtk orthologous se-
quence alignments between human and mouse for each
gene was initially performed; resulting in the exclusion of
304 Refseq accession numbers due to poor conservation
between human and mouse within the promoter se-
quences of these genes. This resulted in 975 Refseq acces-
sion numbers that were used in the modified oPOSSUM
database. Of these 975 accession numbers, 770 (79 %)
were found to have predicted binding sites for NR2E1
within their promoter regions (Fig. 4b) (Additional file 2:
Table S2). [57, 58] These 770 accession numbers were fur-
ther studied in a GO term enrichment analysis using the
DAVID service. The 770 Refseq accession numbers were
first converted to DAVID IDs using the DAVID knowl-
edgebase, and then compared to the DAVID mouse-
background list of genes [50, 59]. The enrichment results
were visualized using the functional annotation module
based on the relevance for each enriched gene to “bio-
logical process” with an initial P value < 0.1, using the
modified Fisher exact test (EASE score) [51, 60, 61]. In
this process, 291 Refseq accession numbers were
discarded as they were not enriched in our list compared
to the mouse background (Fig. 4b). The remaining 479
Refseq accession numbers were interrogated based on
their “biological process” terms. Only terms with a P
value < 0.05 after multiple test correction, using the Bon-
ferroni approach [59, 62], were considered interesting for
further investigation. Table 1 shows the list of GO terms
passing this criterion, Additional file 2: Table S2 list the
differentially expressed genes within these GO terms. As
expected, numerous terms related to cell cycle regulation
were found after performing the GO term enrichment
analysis on the 770 Refseq list. However, terms related to
Fig. 2 Comparative transcriptome investigation of Wt and Nr2e1frc/frc embryos yielded hundreds of candidate-differentially-regulated genes.
a Details of the number of differentially abundant tags (increased or decreased) and the corresponding number of genes between Wt
and Nr2e1frc/frc embryos at each time point. In the exceptional case of a gene having both a significantly up and down tag, it was
counted in both categories. Column one presents the direction of change; column two, the embryonic day of tissue harvest; column
three, the number of tags that had significantly different counts between Wt and Nr2e1frc/frc embryos; column four, the number of tags
having significant different counts that mapped to genes found in the Ensembl (v66) and Refseq (v52) gene collections; and column five,
the number of Refseq genes mapped by the corresponding tags. b The Venn diagram presents the number of up- and down-regulated
genes that were exclusive or shared at each embryonic day (E13.5, E15.5, and E17.5). Bracketed numbers correspond to the total of
differentially-regulated genes between Wt and Nr2e1frc/frc embryos at the corresponding time point
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cell cycle regulation were also found in a similar analysis,
using the initial 1279 Refseq list. This suggested that genes
involved in cell cycle regulation were differentially
expressed in our LongSAGE results when comparing Wt
to Nr2e1frc/frc, but were not enriched for the presence of
NR2E1 binding sites within the promoter regions. In con-
trast, the term “nervous system development” (P < 0.01),
with 64 differentially-regulated genes, was found to be
enriched only after performing the analysis on the 770
Refseq list, again, suggesting the presence of NR2E1 bind-
ing sites within the promoter regions of genes enriched
for this term. Interestingly, similar results were also ob-
tained using a different GO term enrichment software;
“GOstats” yielded significant results for the “nervous sys-
tem development” term (P < 0.001) [63]. Thus, we subse-
quently used the “nervous system development” gene list
from the “DAVID analysis” for further investigations.
Differential expression results validated by literature
We used the tag ratio values of the 64 differentially
expressed genes found in the “nervous system develop-
ment” GO term category to perform hierarchical cluster-
ing (Fig. 5a, Additional file 2: Table S2). We used the
same hierarchical procedure as the one described for the
1279 genes list. Similarly to previously obtained results,
the E13.5 and E15.5 time-points, differential tag ratios
correlated positively (Spearman R = 0.41, P < 0.001), and
the E13.5 and E17.5 yielded a negative correlation value
(Spearman R = −0.34, P < 0.001). However, no signifi-
cance was observed when comparing the E15.5 and
E17.5 time points (Fig. 5b). This suggested that the
differential-tag ratio found between the E13.5, and E15.5
Fig. 3 Hierarchical clustering suggested a stage-specific role for
Nr2e1 in neocortex development. a Tag numbers for each of the
corresponding 1279 genes were retrieved from DiscoverySpace
and hierarchical-clustering was performed prior to visualization in a
heat-map; displaying significant-differential-tag ratios from Wt vs.
Nr2e1frc/frc libraries. The relative expression was calculated based on
the tag ratios from Wt vs. Nr2e1frc/frc libraries and corrected to account
for library sizes; (observed tag counts/total useful tags) X 100,000. Tags
having a count value of “0” (no expressed tags) were adjusted to a
value of “1” for fold change calculations only. Green, down; red, up;
black, no difference; grey, no expressed tags. b Embryonic-stage-specific
differences in expression profiles of the 1279 differently abundant
genes in neocortex development of Wt vs. Nr2e1frc/frc embryos was
demonstrated using Spearman rank correlation. Spearman rank
correlation was performed on gene lists from pairs of embryonic stages
using STATISTICA. Results revealed a significant positive correlation
between the lists corresponding to early and mid-neurogenic stages
(E13.5 vs. E15.5); whereas significant negative correlations were obtained
with the tag ratios corresponding to the early and mid-neurogenic
stages versus the early gliogenic stages (E13.5 vs. E17.5, and E15.5 vs.
E17.5). Column one presents the time-point comparisons; column two,
the valid number of genes included in the analysis; columns three and
four, the corresponding R and P values obtained by Spearman
rank correlation
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libraries were more similar than the one observed in the
E17.5 library; highlighting again the possibility of distinct
roles for Nr2e1 in the neurogenic versus early gliogenic
stages of neocortex development.
As expected, all the Nr2e1frc/frc libraries showed no
tags for Nr2e1. Interestingly, even the Wt libraries,
despite being obtained by LCM for a focused region of
Nr2e1 expression, showed low abundance of Nr2e1 tags
(E13.5, 4; E15.5, 2; and E17.5, 0). Thus, only E13.5
reached significant differential expression between Wt and
Nr2e1 frc/frc (−4.5 fold, P < 0.05). As expected, the number
of tags mapping to Nr2e1 in the Wt libraries showed a
declining trend (Wt E13.5 vs. Wt E17.5, P = 0.06). This is
in agreement with published and publicly-available
expression results [18] (Allen Mouse Brain Atlas,
http://www.brain-map.org/); where Nr2e1 expression
has been observed as early as E8, peaks at E13,
sharply decreases until E18, and is barely detectable
in new-born brains [18]. Hence, at the time point of
lowest Nr2e1 expression (E17.5) the LongSAGE
approach was insufficiently sensitive to detect this latter
gene transcript. Interestingly, our bioinformatics enrich-
ment analysis included Nr2e1 in the list of genes with pre-
dicted NR2E1 binding sites within their promoter regions,
adding support to previous observations proposing a self-
regulating mechanism for Nr2e1 [22, 64].
When analysing large-scale transcriptome-profiling
datasets, the overall level of expression is an important
factor influencing the outcome of statistical significance.
In our LongSAGE libraries, Pten and P21 (Cdkn1a), two
direct targets of Nr2e1 [11, 14, 21], were expressed at
low levels in the VZ/SVZ (total number of tags, Pten:
E13.5, Wt 1, Nr2e1frc/frc 5; E15.5, Wt 1, Nr2e1frc/frc 1; and
Fig. 4 Novel implementation of three computational methods to
generate a focused list of biologically-relevant Nr2e1-candidate-target
genes. a Data mining from the literature allowed generation of a
position-weight matrix representing the binding properties of NR2E1.
The matrix and resulting logo are presented. b Flow chart describing
the novel implementation of three computational methods to
generate a focused list of biologically-relevant Nr2e1-candidate-target
genes. DiscoverySpace was used to generate a compiled list of 1279
Refseq accession numbers, corresponding to genes differentially
regulated between Wt and Nr2e1frc/frc embryos. A customized
oPOSSUM database of predicted conserved TFBS was created by
first aligning all orthologous human-mouse genes using ORCAtk.
During this alignment, 304 of the 1279 differentially regulated
genes were excluded due to a lack of ortholog information or poor
ORCAtk alignment quality. Then the remaining 975 genes with
conserved promoter regions were scanned with the NR2E1 matrix
(as well as all the vertebrate matrices from the JASPAR CORE collection
of transcription factor binding site profiles). Of the 975 scanned genes,
770 contained conserved NR2E1 binding sites. These 770 Refseq
accession numbers were submitted to a gene ontology (GO) term
analysis using DAVID. From the DAVID analysis, 479 Refseq accession
numbers were found to be enriched in GO term categories related to
biological processes
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E17.5, Wt 0, Nr2e1frc/frc 1; P21: E13.5, Wt 0, Nr2e1frc/frc
0; E15.5, Wt 1, Nr2e1frc/frc 3; and E17.5, Wt 1, Nr2e1frc/frc
2) and thus did not reach significance in terms of differ-
ential expression between Wt vs. Nr2e1frc/frc libraries. In
contrast, Nestin, a common marker of proliferating
neural progenitors, which was expressed at mid to high
levels, was significantly down regulated in Nr2e1frc/frc at
E13.5 when compared to Wt (−7.3 fold, P < 0.05) (Fig. 5a,
Additional file 1: Table S1). This correlated with the pre-
viously published observation of reduced numbers of
Nestin-positive cells in the VZ of Nr2e1-null embryos at
E14.5 [11]. In addition, our data suggests that the mech-
anism involves a direct-up regulation by Nr2e1 in Wt, as
Nestin was found within the bioinformatics enrichment
analysis genes with predicted NR2E1 binding sites. An-
other example of our expression results being supported
by the literature is the basic helix-loop-helix (bHLH)
gene Neurog2, which was significantly down regulated in
Nr2e1frc/frc embryos at both E13.5 and E15.5 when com-
pared to Wt (E13.5, −2.8 fold, P < 0.001; E15.5, −5.5 fold,
P < 0.001) (Fig. 5a, Additional file 1: Table S1). These
results correlated with the previously published observa-
tions of reduced expression of Neurog2 in double mu-
tants embryos for Pax6 and Nr2e1 in the rostral
granular zone during neocortex development [65].
Disruptions in Neurog2 expression are also characteristic
of alterations in the pallio-subpallial boundary observed
in Nr2e1-null embryos [66]. Additionally, downstream
candidate genes of the pathway regulated by Neurog2
(i.e. Neurod2, and Tbr1) were found differentially
expressed in our LongSAGE comparison analysis,
arguing in favour of a direct role for Nr2e1 in regulat-
ing this specific pathway during neocortex develop-
ment (Fig. 5a, Additional file 1: Table S1) [65].
TFBS overrepresentation analysis revealed
novel-candidate-NR2E1 co-interactors
Spatial-temporal gene expression is, in general, regulated
by the dual ability of transcription factors to bind specific
DNA sequences and to form complexes with other regula-
tory proteins. NR2E1 has previously been shown to medi-
ate gene regulation with co-interacting partners; forming
regulatory complexes that lead to either direct-target-gene
repression or activation [14, 21, 25, 26]. Interestingly, nu-
clear receptors have also been shown to mediate gene
regulation via interaction with other transcription factors
as co regulators [64, 67, 68]. Based on our Spearman rank
ordering results, we hypothesized that the striking differ-
ence in direction of correlation for differentially abundant
tags between the E13.5-E15.5, E13.5-E17.5, and E15.5-
E17.5 time points, was largely due to the presence of
different Nr2e1 interacting partners at different times in
development. To discover novel candidate co-interactors
of Nr2e1, we designed a computational experiment to
identify TFBS within the vicinity of the predicted NR2E1
binding sites for each differentially-regulated gene found
in the GO term category “nervous system development”.
The identified binding sites were then scored for their
enrichment compared to a randomized list of genes,
thereby generating both a Z and Fisher score. Potential
TFBSs having a Z-score value > 10 and a Fisher score
value < 0.01 were considered enriched and kept for fur-
ther characterization as candidate-NR2E1 co-interactors
(Table 2). We further ascertained the significance of our
candidate-NR2E1 co-interactors list by performing ana-
lyses on random sets of 64 genes extracted from the initial
list of 770 genes obtained through the oPOSSUM-NR2E1
binding motif interrogation step. Corresponding empir-
ical P values based on the Z-scores and Fisher scores of
each of the candidate-NR2E1 co-interactors were
extracted from the random sets of 64 genes and are
summarized in Additional file 4: Table S4.
Table 1 Gene ontology (GO) term analysis revealed enrichment
in relevant biological processes




GO:0006396 ~ RNA processing 55 4.39E-10
GO:0016070 ~ RNA metabolic process 68 7.54E-09
GO:0044267 ~ cellular protein
metabolic process
132 2.96E-04
GO:0007067 ~mitosis 26 3.12E-04
GO:0000280 ~ nuclear division 26 3.12E-04
GO:0015031 ~ protein transport 56 3.58E-04
GO:0045184 ~ establishment of
protein localization
56 4.56E-04
GO:0000087 ~ M phase of mitotic
cell cycle
26 4.66E-04
GO:0046907 ~ intracellular transport 42 6.08E-04
GO:0030163 ~ protein catabolic
process
49 1.13E-03
GO:0044265 ~ cellular macromolecule
catabolic process
52 1.27E-03
GO:0000279 ~ M phase 31 2.35E-03
GO:0051246 ~ regulation of protein
metabolic process
35 3.82E-03
GO:0007399 ~ nervous system
developmentc
64 5.13E-03
GO:0022403 ~ cell cycle phase 33 6.36E-03
GO:0019538 ~ protein metabolic
process
151 6.91E-03
GO:0006886 ~ intracellular protein
transport
28 3.18E-02
GO:0034613 ~ cellular protein
localization
29 4.95E-02
a352 total non-overlapping differentially expressed genes
bhttp://david.abcc.ncifcrf.gov/ease/Help/Technical%20details/
Overrepresentation%20analysis.htm
cterm used in subsequent analyses
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The relevance of these enriched TFBS was also
evaluated based on the expression pattern of their
corresponding transcription factors. For this, we pri-
marily used data from the Allen Mouse Brain Atlas
(http://www.brain-map.org/) at three different time
points (E13.5, E15.5, and E18.5), and included data
from other publically-available resources as required
(Table 2) [69].
The expression data and statistical scores obtained
most strongly supported the biological relevance of
SOX9 (Z-score: 16.97, empirical P value: < 0.001; Fisher
score 1.58E-05, empirical P value: = 0.001); a member of
the SRY-box family. Examination of our LongSAGE data
revealed the presence of tags corresponding to Sox9
throughout the three different time points for both ge-
notypes (data not shown). Additionally, Sox9 has been
reported to function in neural-stem/progenitor-cell
regulation; as does Nr2e1. Together these data support
the hypothesis that SOX9 acts as a co-interactor of
NR2E1 [70]. Thus, the differentially-regulated genes
found in the GO term category “nervous system devel-
opment”, and the number of predicted TFBSs for both
NR2E1 and SOX9 in the promoter region of these genes,
are presented in Table 3 (Additional file 2: Table S2).
These 40 genes represent a rich resource for the bio-
logical examination of Nr2e1 downstream targets. Here
we pursue the top candidate Lhx2, a LIM-homeobox
transcription factor. Lhx2 had the highest number of
predicted binding sites for both NR2E1 and SOX9; 35
Fig. 5 Hierarchical clustering suggested a stage-specific role for
Nr2e1 in nervous system development. a Tag numbers for each
of the 64 genes were retrieved from DiscoverySpace and
hierarchical-clustering was performed prior to visualization in a
heat-map; displaying significant-differential-tag ratios from Wt
vs. Nr2e1frc/frc libraries. The relative expression was calculated
based on the tag ratios from Wt vs. Nr2e1frc/frc libraries and
corrected to account for library sizes; (observed tag counts/
total useful tags) X 100,000. Tags having a count value of “0”
(no expressed tags) were adjusted to a value of “1” for fold
change calculations only. Green, down; red, up; black, no
difference; grey, no expressed tags; bold, key genes in this
analysis. b Embryonic-stage-specific differences in expression
profiles of “nervous system development” genes in neocortex
development of Wt vs. Nr2e1frc/frc embryos was demonstrated
using Spearman rank correlation. Spearman rank correlation
was performed on gene lists from pairs of embryonic stages
using STATISTICA. Results revealed a significant positive
correlation between the lists corresponding to early and
mid-neurogenic stages (E13.5 vs. E15.5); whereas a significant
negative correlation was obtained with the tag ratios
corresponding to the early neurogenic and early gliogenic
stages (E13.5 vs. E17.5). No significance was obtained between
the mid-neurogenic and early gliogenic stages (E15.5 vs. E17.5).
Column one presents the time-point comparisons; column two,
the valid number of genes included in the analysis; columns
three and four, the corresponding R and P values obtained by
Spearman rank correlation
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SP1 190 310 41 23 20.40 6.53E-05 Not available Not available Not available Ubiquitousa ++
Nobox 248 252 47 17 17.70 2.13E-04 Weak, Ubiquitous Moderate, Ubiquitous Weak Not applicable +




Strong, VZ/SVZ Not applicable +++
Arnt-Ahr 243 257 48 16 15.76 4.38E-05 Weak, Ubiquitous Moderate, Ubiquitous Moderate, Ubiquitous Not applicable ++
Nkx2-5 309 191 58 6 15.12 7.92E-07 Not available Not available Not available Absentb -
Gfi1 199 301 42 22 14.27 7.74E-05 Not available Not available Not available Strong, ubiquitousc ++
Lhx3 74 426 20 44 14.00 1.58E-03 Weak Weak Weak Not applicable +




Weak, Ubiquitous Not applicable +
NHLH1 61 439 22 42 13.57 2.00E-05 Strong, Neocortex Weak, Neocortex Weak Not applicable ++
Myb 211 289 46 18 13.49 5.86E-06 Weak, Neocortex Weak, Neocortex Weak Not applicable ++
Roaz (Zfp423) 59 441 19 45 12.99 3.31E-04 Not availablea Not availablea Not available Strong, ubiquitousd ++
FOXI1 189 311 36 28 12.27 3.72E-03 Weak Weak Weak Not applicable +
Prrx2 296 204 53 11 12.26 1.13E-04 Weak Weak Weak Not applicable +
Cebpa 131 369 37 27 11.92 6.32E-07 Weak Weak Weak, Neocortex Not applicable +
Foxa2 177 323 35 29 11.38 2.38E-03 Weak, Ubiquitous Weak, Ubiquitous Weak, Ubiquitous Not applicable +







Sox17 237 263 48 16 11.06 2.06E-05 Weak Weak Weak Not applicable +
Sox5 269 231 51 13 10.61 4.18E-05 Strong, Neocortex Strong, Neocortex Strong, Neocortex Not applicable ++
SRY 267 233 48 16 10.11 6.56E-04 Weak Weak Weak Not applicable +







Bold, most relevant transcription factor according to both the statistical and expression pattern scores; Not available, no expression data available in the ABA (http://www.brain-map.org/, accessed January 10th 2014);
Not applicable, data available in ABA so no need to access other resources
aGray et al. (PMID: 15618518) showed expression in the central nervous system, including the brain ventricular layers at E13.5
bExpression restricted to the developing striatum at E14.5 according to Eurexpress (http://www.eurexpress.org/)
cWallis et al. (PMID: 12441305) showed expression in the developing forebrain at E12.5














and 13 respectively. Visualization of the predicted bind-
ing sites within the promoter region of Lhx2 revealed a
clustered distribution that was located within highly
conserved DNA (Fig. 6). Localization within conserved
DNA further suggested a function for these binding sites
throughout evolution. Evidence from the literature high-
lights a spatial-temporal dynamic role for Lhx2 in the
developing forebrain. Early in development (E10.5-
E11.5), Lhx2 has been shown to work as a fate determin-
ant of cortical identity [71]. Later in development,
distinct roles have been described for Lhx2 depending
on the forebrain structures involved; including a role in
regulating progenitor cell differentiation in neocortex
development (E11.5-E13.5) and a role in the neurogenic
to gliogenic switch in hippocampal development
(E14.5-E15.5) [72, 73]. Thus, our data, combined with
the literature, support Lhx2 as a direct target of co-
regulation by NR2E1 and SOX9.
Differential expression of the transcription factor Lhx2
validated our LongSAGE results
To expand our understanding of the relationship be-
tween Nr2e1 and Lhx2, and simultaneously further val-
idate the results obtained from the LongSAGE tag
libraries, we undertook two biological assays; one each
in vitro and in vivo. First we retrieved with Discovery-
Space 4.0 the LongSAGE tag sequence mapping to Lhx2,
and the corrected number of tags from each library
(Fig. 7a). This showed that Lhx2 levels were significantly
increased in Nr2e1frc/frc libraries at two different time
points (E13.5, and E15.5).
For in vitro studies, we chose a method of neurogenesis
from adherent-monoculture of ESC, which sequentially
mimics the development of cortical neurons over the
course of 21 days of differentiation [74]. In this system:
neural induction starts at day 0 (d0) of differentiation;
neurogenesis starts at d6 with the generation of subplate
neurons and deep layer neurons between d7 and d9,
followed by upper cortical neurons around d12; finally
there is a wave of gliogenesis by d21 [75]. The formation
of subplate neurons corresponds to in vivo E10.5-E13.5,
deep layer neurons to E11.4-E14.5, and upper cortical
neurons to E13.5-E16.5 [75]. Hence, this culture system
encompass the key time periods for the function of Nr2e1
in brain development. Using this method, we first detected
Nr2e1 expression at d6, which then increased and peaked
at d12 (data not shown). Further investigation using qRT-
PCR at this latter time point not only showed a significant
difference between Wt and Nr2e1frc/frc cells for the Nr2e1
gene (Fig. 7b), but also demonstrated a significant increase
in expression in Nr2e1frc/frc cells when compared to Wt
cells for the Lhx2 gene (P < 0.01) (Fig. 7c) [75]. This result
was consistent with a model of Lhx2 being a direct target
of, and repressed by, Nr2e1.
Table 3 Overrepresentation analysis revealed candidate-direct-
target genes of Nr2e1
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For in vivo studies, we examined the expression pat-
tern of the Lhx2 protein by immunofluorescence in Wt
and Nr2e1frc/frc E15.5 embryos. The results showed simi-
lar Lhx2 protein localization when comparing Wt and
Nr2e1frc/frc embryos; along the VZ/SVZ of the developing
forebrain. Furthermore, for both Wt and Nr2e1frc/frc, ex-
pression levels varied from high in the medial pallium to
low in the dorsal pallium (Fig. 7d). However, relative
quantification of Lhx2 between Wt and Nr2e1frc/frc,
along the VZ/SVZ of the dorsal-lateral telencephalon, re-
vealed a significant increase of Lhx2 protein in the
Nr2e1frc/frc embryos when compared to Wt (P < 0.01)
(Fig. 7e). Thus, the significant increase at the mRNA
level for the Lhx2 gene results in a significant increase at
the protein level along the VZ/SVZ of the dorsal-lateral
telencephalon at E15.5. These data add further support
to the hypothesis that Nr2e1 directly-negatively regulates
Lhx2 expression in the dorsal-lateral telencephalon dur-
ing development.
Conclusions
In this work, we have generated a list of 1279 genes that
are differentially expressed in response to altered Nr2e1
expression during in vivo neocortex development; this
list was a critical part of our own studies, but is also an
important resource for others (Additional file 1: Table
and Additional file 2: Table S2). To create this list, we
profiled the transcriptomes of Wt and Nr2e1frc/frc em-
bryos by generating LongSAGE libraries through LCM
of the VZ/SVZ from the dorsal-lateral telencephalon. To
further focus the work on the role of Nr2e1 during neo-
cortex development, we chose two time points that
spanned the early to mid-neurogenic stages (E13.5,
E15.5), and one time point corresponding to the early
switch from neurogenesis to gliogenesis (E17.5). Thus,
from six LongSAGE libraries we identified 1279 candi-
date genes comprising both direct and indirect targets of
Nr2e1 during neocortex development. This list can now
be mined by us, and many other groups for the antici-
pated numerous co-suppressors, co-activators, and dir-
ect targets making up the molecular mechanisms of the
nuclear-receptor transcription-factor Nr2e1.
We have further refined this list of 1279 differentially
expressed genes, culminating in a focused list of 64 can-
didate direct-targets of NR2E1 binding during nervous
system development, for our own studies and as a re-
source for others (Additional file 2: Table S2). This was
accomplished by performing two sequential analyses; 1)
a TFBSs prediction analysis, using oPOSSUM, to identify
novel direct targets of Nr2e1, and 2) a GO term overrep-
resentation analysis, to extract biological meaning from
the latter generated list. This procedure included the
generation of a novel NR2E1 PWM based on available
information from the literature (Additional file 3: Table
S3); the derived matrix and logo are provided (Fig. 4a).
We used this matrix, in combination with the Long-
SAGE results, in a bioinformatic experiment to identify
novel direct-target genes of Nr2e1. The resulting list of
GO terms coming from this analysis (Table 1) contained
genes differentially expressed, and predicted to contain
NR2E1 binding sites within their promoter regions
(Additional file 2: Table S2). The GO term category
“nervous system development” contained 64 such genes
(Fig. 5a, Additional file 2: Table S2); a list that was used
in subsequent analyses.
Our approach suggested distinct roles for Nr2e1 dur-
ing different neocortex developmental stages. Analyses
performed on the differential-tag ratio for the 1279
Refseq accession numbers of differentially-regulated
genes retrieved from the Wt and Nr2e1frc/.frc libraries, re-
vealed a positive correlation of the differential abun-
dance at E13.5 and E15.5, whereas a negative correlation
was obtained when comparing the two previous time
points to E17.5 (Fig. 3). Thus, the differential-tag ratios
Fig. 6 Lhx2 contains enriched clusters of NR2E1 and SOX9 binding sites in highly conserved regions. Presented is the ~17 kb of genomic
sequence 5′ to, and surrounding, the Lhx2 transcription start site. NR2E1 binding sites are indicated in black, and SOX9 binding sites are indicated in
red. NR2E1 binding site coordinates were derived from the position-weight matrix (PWM) described in the current manuscript; SOX9 binding sites
coordinates were derived from the PWM stored in the JASPAR database (http://jaspar.binf.ku.dk/cgi-bin/jaspar_db.pl). Conservation, alignment of 100
vertebrate species from the University of California, Santa Cruz genome browser (UCSC: http://genome.ucsc.edu/); thick horizontal line, first exon of
Lhx2; arrow, transcription start site and sense
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found at E13.5 and E15.5 were more similar to each
other than when compared to E17.5. From E13.5 to
E17.5, the neocortex undergoes drastic changes,
including the formation of the SVZ, a layer of cells be-
ing seeded by the VZ, and a progressive switch from
neurogenesis to gliogenesis. Our results indicate that
Fig. 7 Validation of the differential abundance of Lhx2 LongSAGE tags in Wt vs. Nr2e1frc/frc embryos. a The tag count results, mapping to Lhx2 at
the three different embryonic days, are presented. Columns one to three present the tag sequence, accession number, and gene symbol
corresponding to Lhx2; columns four to six, the corrected tag numbers recovered from DiscoverySpace in both Wt and Nr2e1frc/frc embryos at
each time point (E13.5, 15.5, and 17.5); column seven, the fold change between the tag numbers corresponding to Lhx2 found in Wt and
Nr2e1frc/frc embryos at each time point; and column eight, the associated P values obtained using the Audic-Claverie statistical method. According
to this approach, Lhx2 expression level is significantly upregulated at both E13.5 and E15.5 in Nr2e1frc/frc embryos. b Wt embryonic stem cells
(ESC) submitted to a neurogenic differentiation protocol demonstrated expression of Nr2e1 at 12 days of differentiation (d12) whereas, as
expected, Nr2e1frc/frc ESC did not express Nr2e1 (*, P < 0.001). c Quantitative RT-PCR reveals that the Lhx2 mRNA level is upregulated by ~3.6 fold
in Nr2e1frc/frc ESC at d12 compared to Wt ESC (*, P < 0.01). d Immunofluorescence using an anti-Lhx2 antibody (green) demonstrated a similar
expression pattern for the Lhx2 protein along the ventricular/subventricular zone (VZ/SVZ) of the lateral telencephalon in E15.5 Nr2e1frc/frc embryos
compared to Wt. White arrows, medial pallium; red arrows, dorsal pallium; scale bar, 200 μm. e Lhx2 protein level was increased by ~1.3 fold
along the VZ/SVZ of the lateral telencephalon in E15.5 Nr2e1frc/frc embryos compared to Wt (*, P < 0.05). (c), (d), (e) Sample Student’s t-test were
performed, N = 3; error bars, standard error of the mean
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Nr2e1 has a more similar effect in the early stages of
neurogenesis (E13.5 and E15.5) compared to later
stages when the switch from neurogenesis to gliogen-
esis occurs. The mechanism driving these changes may
depend on the level of Nr2e1 expression, which peaks
at E13.5 and gradually decreases until birth [18].
The SOX9 transcription factor may be an important
co-interactor of NR2E1 in regulating numerous target
genes during nervous system development. A co-factor
analysis revealed enrichment for binding sites predicted
to be bound by SOX9 within the vicinity of the predicted
NR2E1 binding sites (Table 2); results that remained sig-
nificant after calculating empirical P values on our list of
candidate co-interactors (Additional file 4: Table S4). In
addition, the spatial, temporal, and strength of expres-
sion of Sox9 strongly supported a biological relationship
with Nr2e1 [70]. Interestingly, others have shown that
Sox9 may be involved in the acquisition of gliogenic
competence of neural stem/progenitor cells during cen-
tral nervous system (CNS) development [76]. Together
these data suggest that co-interaction between the SOX9
transcription factor and NR2E1 may regulate the expres-
sion of 40 of the 64 genes involved in nervous system
development (Additional file 2: Table S2).
The Sox family of transcription factors may generally
be important co-interactors of Nr2e1 in regulating target
genes during nervous system development. This family
comprises 20 genes with several members expressed in
neural stem/progenitor cells of the CNS, and peripheral
nervous system [77–79]. They have been shown to act
as either transcriptional activators or repressors by bind-
ing to similar (A/T)(A/T)CAA(A/T)G DNA motifs [78].
Recently, one of these family members, Sox2, has been
shown to form a regulatory complex with Nr2e1 in adult
NSC [64]. Interestingly, our co-factor TFBSs analysis re-
vealed enrichment for the presence of associated binding
sites not just for SOX9, but also three additional Sox
family members (Sox17, Sox5, and SRY) within the
vicinity of predicted NR2E1 binding sites for genes of
the “nervous system development” GO term category
(Table 2). These additional Sox family members also
showed expression overlap with Nr2e1, and at least one
of these members, Sox5 has been shown to bind to
Fezf2-conserved-enhancer sequences, resulting in a dir-
ect repression of Fezf2 in neocortex development [80].
LongSAGE tags mapping to Sox5 were found in our li-
braries and Fezf2 was found significantly upregulated in
the Nr2e1frc/frc library at E15.5 (7.4 fold, P < 0.05, Fig. 5a).
Hence our data suggests a specific testable hypothesis by
which Nr2e1 potentially regulates Fezf2 expression
through its interaction via the Sox5 protein in neocortex
development. In conclusion, our data supports the hy-
pothesis that generally the Sox family members play an
important role as co-interactors of NR2E1.
Lhx2 may be an important direct-target gene of
Nr2e1, with SOX9 as a co-interactor. In Nr2e1-null
embryos, premature neurogenesis has been reported
to occur from E9.5 to E14.5 in both the dorsal and
ventral telencephalon [9]. Overexpression of Lhx2 has
been reported to prolong neurogenesis in hippocam-
pal development, resulting in generation of neurons
from progenitors that would normally produce astro-
cytes [72]. Additionally, conditional inactivation of
Lhx2 in neocortical development affects the fate of
PC, resulting in a phenotype highly similar to that
observed in Nr2e1-null embryos; with a reduction in
the number of PC populating the VZ and premature
neurogenesis in the neocortex of Lhx2-null embryos
[73]. This latter phenomenon appears to involve the
notch signalling pathway, with a downregulation of
Hes1 being observed along the VZ of Lhx2-null em-
bryos and aberrant expression of the Notch encoding
gene along the medial to lateral dorsal telencephalon
[73]. Notch pathway genes such as Notch1, Hes5, and
Hes6 were also found differentially regulated in the
Nr2e1frc/frc library when compared to Wt in our
LongSAGE analysis (Notch1, E13.5, −6.8 fold, P < 0.05;
Hes5, E13.5, −6.8 fold, P < 0.01; E17.5, −10.3 fold, P < 0.01;
Hes6, E13.5, 9 fold, P < 0.001) (Fig. 5a, Additional file 1:
Table S1 and Additional file 2: Table S2). Protein regula-
tory networks in NSC have been demonstrated to be
highly dosage dependent. For instance, phenotypic ana-
lyses of Pax6 in gain- or loss-of-function mutant cortices
have shown similar phenotypic outcome, with both more
or less of the protein resulting in increased neurogenesis
throughout development [81]. Hence, akin to Pax6, our
current results highlight a testable hypothesis in which
premature neurogenesis observed in Nr2e1frc/frc em-
bryos [9] could be due to the upregulation of Lhx2
protein along the VZ/SVZ of the dorsal telenceph-
alon; a phenomenon that most likely includes the
concerted effect of deregulation of other Notch path-
way encoding genes. Our analysis also predicted that
the transcription factor pathway regulated by NR2E1
involves interaction with SOX9, which has been
shown to be involved in the acquisition of gliogenic
competence of neural stem/progenitor cells during
CNS development [76]. Hence, our results highlight
yet another testable hypothesis for the discovery of a
possible novel pathway by which Nr2e1 regulates neuro-
genesis, which includes Lhx2 as one of the direct-target
genes, and SOX9 as a co-interactor.
Methods
Ethics statement
All procedures involving animals were in accordance
with the Canadian Council on Animal Care and UBC
Animal Care Committee (Protocol A11-0412).
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LongSAGE libraries generation
Libraries were generated from tissue samples obtained
by LCM of dorsal VZ/SVZ from the telencephalon of
wild-type (Wt) and Nr2e1frc/frc embryos at E13.5, E15.5,
and E17.5 as described by us previously [31]. Briefly, one
embryo per genotype at each developmental time point
was sectioned at 20 μm thickness to generate the tissue
samples. Sections from each embryo underwent LCM,
and the isolated tissue was pooled and RNA extracted
using an RNeasy Micro Kit (Qiagen Inc., Mississauga,
Ontario, Canada). The LongSAGE-lite method was used
to construct the libraries using 15 to 86 ng of high
quality RNA from each embryo [31, 37, 82]. Each li-
brary was sequenced to a depth of >100,000 raw tags
and the processed data is accessible on the Mouse
Atlas of Gene Expression project website (http://
www.mouseatlas.org/) and the NIH SAGEmap data re-
pository http://www.ncbi.nlm.nih.gov/projects/SAGE/) [83].
LongSAGE data analysis
LongSAGE libraries were analysed using the Discovery-
Space 4.0 application (http://www.bcgsc.ca/platform/
bioinfo/software/ds) [44]. The library data were electron-
ically filtered based on procedures previously described
by us [45, 84]. Briefly, duplicated ditags (identical copies
of a ditag) and singletons (tags counted only once) were
retained for analysis. Sequence data were filtered for bad
tags (tags with one N-base call), and linker-derived tags
(artefact tags). Only tags with a sequence quality factor
greater than 99 % were included in the analysis. Se-
quence tag comparisons between Wt and Nr2e1frc/frc li-
braries were performed and a P-value cutoff < 0.05 using
the Audic-Claverie statistical method was used [46].
LongSAGE tags exhibiting differential expression levels
were mapped to transcripts in the NCBI Reference
Sequence (Refseq) collection (version 52, released March
8th 2012) and Ensembl gene collection (version 66, re-
leased February 2012).
NR2E1 binding site profile construction
No position-weight matrix (PWM) was available in pub-
lic databases to model NR2E1 transcription factor bind-
ing site (TFBS) specificity. Thus, a literature review was
conducted and the sequences reported to be bound by
NR2E1 were compiled. Next, the MEME motif discovery
tool (http://meme-suite.org/) was applied, with default
parameter settings, to identify a DNA sequence pattern
within the data [85].
oPOSSUM promoter analysis
A pooled list of RefSeq accession numbers for tran-
scripts exhibiting differential expression between Wt
and Nr2e1frc/frc genotypes, at least at one of the three
different time points, was subjected to an oPOSSUM
TFBS analysis. The oPOSSUM software was run
using default settings with both the constructed
NR2E1 PWM and the JASPAR core vertebrate PWM
collection (http://www.cisreg.ca/oPOSSUM/) [39, 40].
Briefly, for each Refseq accession number, oPOSSUM
automatically retrieved the genomic DNA sequences
around annotated transcription start sites (TSS) in
Ensembl (plus 5000 bp of both upstream and down-
stream sequence), performed an alignment of the
orthologous sequences (human to mouse), and ex-
tracted non-coding DNA sequences that are con-
served above a predefined threshold (default: top
10 % of conserved regions, minimum conservation
70 %). oPOSSUM results include the positions of
predicted TFBSs, and the scores of the sites.
GO term enrichment analysis
Refseq accession numbers for those genes predicted
to contain NR2E1 binding sites in the oPOSSUM
database were submitted to the DAVID service
(http://david.abcc.ncifcrf.gov/summary.jsp) for GO
term annotation enrichment analysis [50, 51]. The Refseq
identifiers were converted to DAVID identifiers (IDs),
using the DAVID knowledgebase [59]. GO biological-
process term enrichment was assessed relative to the en-
tire set of mouse genes as provided by DAVID. Results
were filtered to exclude those enriched GO terms associ-
ated with 2 or less submitted genes. A significant P-value
threshold was applied using a multiple testing correc-
tion (Bonferroni, P value < 0.05).
Clustering-correlation
Expression clustering was performed on the
differential-tag ratios of the initial list of 1279 differen-
tially expressed genes, and the genes annotated within
the enriched GO term “nervous system development”
category using the Gene Cluster software [47]. Hier-
archical clustering was performed on both the gene list
and the embryonic stages using Spearman correlation
with complete linkage clustering. Tag counts were cor-
rected to account for library sizes; (observed tag
counts/total useful tags) X 100,000, and tags having a
count value of “0” (no expressed tags) were adjusted to
a value of “1” for fold change calculations only. Spear-
man rank correlation analyses on the differential-tag ra-
tios were performed using STATISTICA 12.0 (Statsoft,
Inc., Tulsa, OK, USA). For these latter analyses, genes
were considered as valid when their differential-tag ra-
tios between Wt and Nr2e1frc/frc were not equal to zero.
Co-factor TFBS enrichment analysis and transcription
factor candidate evaluation
A customized bioinformatics analysis, based on the oPOS-
SUM combination site analysis feature, was performed to
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identify TFBS patterns that were significantly enriched in
the vicinity of predicted NR2E1 binding sites for the 64
candidate genes found in the “nervous system develop-
ment” GO term category. Sites within 100 bp of predicted
NR2E1 binding sites were retrieved from the oPOSSUM
database. Sites overlapping an NR2E1 motif were ex-
cluded. Both the NR2E1 sites and proximal sites were sub-
ject to the default oPOSSUM parameters of conservation
level (top 10 % of conserved regions with a minimum per-
centage identity of 70 %), threshold level (default matrix
score threshold of 80 %), and search region level (5000 bp
upstream and downstream of TSS). The analysis was per-
formed against a background of 500 genes selected ran-
domly from the oPOSSUM database. Over-representation
results were considered significant based on a Z score
(>10) and a Fisher score (<0.01) according to the literature
[40]. To further validate the significance of these results,
additional oPOSSUM co-factor analyses were performed
on 1000 sets of 64 genes selected randomly from the list
of 770 genes enriched for GO terms, using the same ana-
lysis parameters and the same set of 500 background
genes as the one described above for the “nervous system
development” gene set. The significance of the Z and
Fisher score for each of the co-factors was deter-
mined by empirical P value, computed as “n/N”
where “n” is the number of times the Z and Fisher
score from set of the random trials for the co-factor
was more significant than the Z and Fisher score
from the “nervous system development” set for that
co-factor, divided by the total number “N” of random
trials (in this case 1000). These results are shown in
Additional file 4: Table S4.
Transcription factors with enriched binding site predic-
tions were additionally assessed for their expression pat-
tern at E13.5, 15.5, and 18.5 using images from the
Allen Mouse Brain Atlas (ABA, http://www.brain-
map.org/) [69]. Expression results from transcription fac-
tors with enriched binding site predictions that were un-
available from the ABA were evaluated using other
publicly available resources; Eurexpress (http://www.eur-
express.org/ee/), GenePaint (http://www.genepaint.org/
Frameset.html), and the primary literature [86, 87]. The
expression pattern was summarized according to the spe-
cificity and strength of the expression along the VZ/SVZ,
and other forebrain structures. The relevance of the ex-
pression pattern for each transcription factor was scored
as absent (−), low (+), moderate (++), or high (+++);
where absence of VZ/SVZ expression, or ubiquitous ex-
pression in the entire embryo forebrain, was scored as +,
whereas strong and restricted expression along the
VZ/SVZ was scored as +++. The transcription factor
having a high score (+++) was retained as the most in-
teresting candidate. For the highest-scoring transcrip-
tion factors we cross-validated the expression pattern
by looking for the number of corresponding tags in
the LongSAGE libraries.
Embryos preparation
Timed-pregnant mice were euthanized by cervical dis-
location, and embryos at E15.5 were dissected and
fixed in 4 % paraformaldehyde (PFA) with 0.1 M PO
buffer (0.1 M Na2HPO4, pH 8.0) for 6 h at 4 °C. The
embryos were then cryoprotected as described in the
literature, and embedded in optimal cutting
temperature (OCT) compound (Tissue-tek, Torrance,
California, USA) on dry ice [11]. Embryos were sec-
tioned at 20 μm using a Cryo Star HM550 cryostat
(MICROM International, Kalamazoo, Michigan, USA),
and mounted for immunofluorescence.
Immunofluorescence and imaging analysis
For antibody staining, 20 μm sagittal cryosections from
embryos were rehydrated in sequential washes of 1x
phosphate buffered saline (PBS), permeabilized in PBS
with 0.3 % triton, and blocked with 1 % BSA (bovine
serum albumin) in PBS triton 0.3 % for 1 h at room
temperature. Goat anti-Lhx2 primary antibody (1:1000)
(Santa Cruz, Dallas, TX, USA, sc-19344) was incubated
overnight at 4 °C. Rabbit anti-goat Alexa 488 (1:1000)
(Invitrogen, Burlington, Ontario, Canada, A21222) was
incubated for 2 h at room temperature in the dark. Tiled
images were retrieved with an Olympus BX61 motorized
fluorescence microscope at 20X magnification (Olympus
America Inc., Center Valley, Pennsylvania, USA). Inten-
sity quantification was performed using Image-Pro
(Media Cybernetics Inc., Bethesda, Maryland, USA). The
relative intensity level of Lhx2 was calculated as de-
scribed in the literature [88]. Briefly, the sum of the sig-
nal intensity was divided by the area selected and
multiplied by the thickness of the section and the num-
ber of sections. A background correction was applied
using the signal intensity resulting from Hoechst stain-
ing for each sections quantified. A total of 28 different
sections were assessed on six embryos, three different
animals for each genotype (Wt and Nr2e1frc/frc). All
values represent the mean ± standard error of the mean
(SEM). Statistical analysis was performed using Student’s
t-test.
Embryonic stem cells culture
ESC from Wt and Nr2e1frc/frc blastocysts were derived,
and maintained in culture as described in the litera-
ture [89]. The two cell lines used were mEMS1239
(B6129F1-Nr2e1frc/frc, Hprt1b-m3/Y), and mEMS1271
(B6129F1-Nr2e1+/+, Hprt1b-m3/Y).
The ESC differentiation procedure involved the use of
an adapted method of neurogenesis from adherent mono-
culture [74, 75]. Briefly, the cells were seeded at low
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density (~10,000 cells/mm2) on gelatin coated dishes, in a
chemically defined medium exempt of cyclopamine, and
maintained in culture for 12 days (fresh media every two
days). RNA aliquots were prepared on day 12 and were
used for quantitative RT-PCR (qRT-PCR).
Quantitative RT-PCR
RNA from ESC grown in an adapted method of neurogen-
esis from adherent monoculture, collected on day 12, was
extracted using Qiagen RNA Mini Plus kit (Qiagen Inc.,
Mississauga, Ontario, Canada). RNA was treated with
Qiagen DNase kit (Qiagen Inc., Mississauga, Ontario,
Canada), and cDNA was generated using Superscript III
Master Mix kit (Invitrogen, Burlington, Ontario, Canada).
cDNA quantification was performed using ABI Taqman®
assays specifically designed for Nr2e1 (Mm00455855_m1),
and Lhx2 (Mm00839783_m1) (Applied Biosystems Inc.,
Foster city, USA). The 7500 fast real-time PCR system
and Taqman® fast universal PCR Master Mix were used
(Applied Biosystems Inc., Foster city, USA). The cycle
threshold (Ct) value was defined as the number of cy-
cles required for the fluorescent signal to cross a
threshold above the background signal, and is inversely
proportional to the amount of target cDNA. All values
represent the mean ± SEM. Statistical analysis was per-
formed using Student’s t-test.
Availability of supporting data
LongSAGE processed data is accessible on the
Mouse Atlas of Gene Expression project website
(http://www.mouseatlas.org/) and the NIH SAGEmap
data repository (http://www.ncbi.nlm.nih.gov/projects/
SAGE/). All additional supporting data is included as
additional files.
Additional files
Additional file 1: Table S1. List of the 1387 differentially abundant
tag sequences mapping to the 1279 genes, differentially expressed in
response to altered Nr2e1 levels during in vivo neocortex development
and the corresponding tag numbers, calculated fold changes and P
values at E13.5, E15.5, and E17.5. Columns one and two present the
gene ID/symbol, associated tag sequence(s) and corresponding Refseq
ID for each gene. Columns three and four, seven and eight, eleven and
twelve present the number of tags found in Wt and Nr2e1frc/frc libraries
at E13.5, E15.5, and E17.5 inclusively. Column five, nine, and thirteen
present the fold change values resulting from calculations based on the
tag number values found in the previous columns (details, see
Methods). Column six, ten, and fourteen present the associated
P values calculated using the Audic-Claverie statistical test for each
corresponding tags at the three
different time points (E13.5, E15.5 and E17.5).
Additional file 2: Table S2. List of the 1279 genes, differentially
expressed in response to altered Nr2e1 levels during in vivo neocortex
development, and the summary of significant findings for each. Columns
one and two present the gene ID/symbol and associated transcript ID for
each gene. Columns three to five present the genes having significantly
differentially abundant tags at E13.5, E15.5, and E17.5, respectively.
Columns six to nine present the genes retained after performing
subsequent bioinformatics analyses. *, Multiple tags that were either
up- or down-regulated but mapped to the same gene; details of the tag
sequences and the direction of change are depicted. NA, not applicable.
Additional file 3: Table S3. Nr2e1 binding sites containing sequences
extracted from the literature and used to generate a position weight
matrix. Columns one and two present the gene names and species
origin of the DNA sequence analyzed. Column three presents the DNA
sequence analyzed. Column four presents the PAZAR ID matching the
DNA sequence presented in column three. Column five presents the
PubMed ID associated with the manuscript from which the sequences
were derived. NA, not applicable.
Additional file 4: Table S4. Empirical P values extracted from the
Z-scores and Fisher scores of each candidate-NR2E1 co-interactors.
Column one presents the transcription factor symbol. Column two and
three present the calculated empirical P values for both the Z-score
and Fisher score of the corresponding transcription factor.
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